Search Results - "Kanni, T"

Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis? by Kanni, T., Zenker, O., Habel, M., Riedemann, N., Giamarellos‐Bourboulis, E.J.

“…Summary Background Despite the heavy purulence observed in hidradenitis suppurativa (HS), the kinetics of complement anaphylatoxins acting to prime chemotaxis…”
Get full text

Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity by Zouboulis, C.C., Tzellos, T., Kyrgidis, A., Jemec, G.B.E., Bechara, F.G., Giamarellos‐Bourboulis, E.J., Ingram, J.R., Kanni, T., Karagiannidis, I., Martorell, A., Matusiak, Ł., Pinter, A., Prens, E.P., Presser, D., Schneider‐Burrus, S., von Stebut, E., Szepietowski, J.C., Zee, H.H., Wilden, S.M., Sabat, R., Sinclair, R., Vekic, D., Haes, P., Marmol, V., Alavi, A., Gulliver, W., Nassif, A., Nikolakis, G., Podda, M., Antoniou, C., Delli, F.S., Dessinioti, C., Patsatsi, A., Trigoni, A.P., Zisimou, C., Bettoli, V., Garcovich, S., Boer, J., Horváth, B., Ingvarsson, G., Puig, L., Hunger, R.E., Emtestam, L., Danby, F.W., Kimball, A.B.

“…Summary Background A validated tool for the dynamic severity assessment of hidradenitis suppurativa/acne inversa (HS) is lacking. Objectives To develop and…”
Get full text

Clinical efficacy of complement C5a inhibition by IFX‐1 in hidradenitis suppurativa: an open‐label single‐arm trial in patients not eligible for adalimumab by Giamarellos‐Bourboulis, E.J., Argyropoulou, M., Kanni, T., Spyridopoulos, T., Otto, I., Zenker, O., Guo, R., Riedemann, N.C.

Get full text

MABp1 targeting interleukin‐1α in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open‐label extension period by Kanni, T., Argyropoulou, M., Dinarello, C. A., Simard, J., Giamarellos‐Bourboulis, E. J.

Get full text

Cost‐savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real‐world cohort by Argyropoulou, M., Kanni, T., Kyprianou, M., Melachroinopoulos, N., Giamarellos‐Bourboulis, E.J.

“…Summary Background The introduction of adalimumab in the management of hidradenitis suppurativa (HS) raises questions regarding the cost‐efficacy of treatment…”
Get full text

Cost‐savings in hidradenitis suppurativa by Argyropoulou, M., Kanni, T., Kyprianou, M., Melachroinopoulos, N., Giamarellos‐Bourboulis, E. J.

“…Summary Hidradenitis suppurativa (HS) is a common skin disorder that affects almost 1% of people in Europe. HS causes boils to form in areas of the skin with…”
Get full text

Complement in hidradenitis suppurativa by Kanni, T., Zenker, O., Habel, M., Riedemann, N., Giamarellos‐Bourboulis, E.J.

“…Summary This is a study on the pathogenesis (causes) of hidradenitis suppurativa (HS). HS is a common skin disorder that affects almost 1% of people in Europe…”
Get full text

Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa by Savva, A., Kanni, T., Damoraki, G., Kotsaki, A., Giatrakou, S., Grech, I., Katoulis, A., Papadavid, E., Giamarellos-Bourboulis, E.J.

“…Summary Background  Recent evidence has suggested that deranged immune responses play a role in the pathogenesis of hidradenitis suppurativa (HS). Objectives …”
Get full text

Ultrasound aids in diagnosis and severity assessment of hidradenitis suppurativa by Kelekis, N.L., Efstathopoulos, E., Balanika, A., Spyridopoulos, T.N., Pelekanou, A., Kanni, T., Savva, A., Brountzos, E., Giamarellos-Bourboulis, E.J.

Get full text

化脓性汗腺炎中的成本节约 by Argyropoulou, M., Kanni, T., Kyprianou, M., Melachroinopoulos, N., Giamarellos‐Bourboulis, E.J.

“…Summary 化脓性汗腺炎(HS)是一种常见的皮肤病,欧洲近 1% 的人口受其困扰。HS 使存在汗腺的皮肤(如腋窝、乳房、腹股沟和臀部)形成脓肿。该病以周期性为特征,在一个周期中,症状加重,脓疱逐渐增大并破裂,产生脓血。这项在希腊雅典 ATTIKON…”
Get full text

化脓性汗腺炎患者的补体 by Kanni, T., Zenker, O., Habel, M., Riedemann, N., Giamarellos‐Bourboulis, E.J.

“…Summary…”
Get full text

B-068 Plasma calprotectin as an index of draining tunnel formation in Hidradenitis suppurativa by Havelka, A, Kanni, T, Giamarellos-Bourboulis, E J

“…Abstract Background Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disease which affects areas rich in apocrine glands. The main disease…”
Get full text

化脓性汗腺炎中的成本节约 by Argyropoulou, M., Kanni, T., Kyprianou, M., Melachroinopoulos, N., Giamarellos‐Bourboulis, E.J.

Get full text

Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativa: Polymorphisms of TLR4 and TNF genes in hidradenitis suppurativa by Savva, A., Kanni, T., Damoraki, G., Kotsaki, A., Giatrakou, S., Grech, I., Katoulis, A., Papadavid, E., Giamarellos-Bourboulis, E.J.

Get full text

Cryoanalgesia with a CoolSense Device in Patients Treated with Botulinum Toxin-A for Palmar-Plantar Hyperhidrosis: A Self-Controlled Study by Kanni, Theodora, Agiasofitou, Efthimia, Markantoni, Vasiliki, Tzanetakou, Vasiliki, Katoulis, Alexander, Gregoriou, Stamatios, Rigopoulos, Dimitrios, Kontochristopoulos, George

Get full text

Ultrasound aids in diagnosis and severity assessment of hidradenitis suppurativa: Correspondence by Kelekis, N.L., Efstathopoulos, E., Balanika, A., Spyridopoulos, T.N., Pelekanou, A., Kanni, T., Savva, A., Brountzos, E., Giamarellos-Bourboulis, E.J.

Get full text

A circulating factor modulates apoptosis of lymphocytes and monocytes after multiple trauma by Kotsaki, A, Savva, A, Mouktaroudi, M, Kanni, T, Giamarellos-Bourboulis, E, Kotzampassi, K

Get full text

Effect of the novel influenza A (H1N1) virus in the human immune system by Antonopoulou, A, Raftogiannis, M, Baziaka, F, Koutoukas, P, Savva, A, Kanni, T, Georgitsi, M, Pistiki, A, Giamarellos-Bourboulis, EJ

Get full text